Search | HMA-EMA Catalogues of real-world data sources and studies

Results(96)

DARWIN EU® - Enhanced Preparedness of the DARWIN EU Network for regulatory questions in oncology – DARWIN OncoNet

Croatia

Denmark

Estonia

Finland

France

Greece

Hungary

Italy

Netherlands

Norway

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000000824

First published:

10/11/2025

Last updated 10/11/2025

Study Planned

DARWIN EU® - Capturing obesity in DARWIN EU

Belgium

Croatia

Denmark

France

Germany

Greece

Netherlands

Portugal

Spain

EU PAS number:

EUPAS1000000820

First published:

10/11/2025

Last updated 16/02/2026

Study Planned

DARWIN EU® - Enabling pregnancy and mother-child research in DARWIN EU® Data Network - PeriNet

Croatia

Denmark

Finland

France

Germany

Hungary

Netherlands

Norway

Portugal

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000000812

First published:

06/11/2025

Last updated 06/11/2025

Study Planned

DARWIN EU® - Feasibility of studies on early (pre-symptomatic) stages of type 1 diabetes mellitus in the DARWIN EU® network

Denmark

Finland

France

Hungary

Netherlands

Spain

EU PAS number:

EUPAS1000000756

First published:

24/09/2025

Last updated 08/04/2026

Study Finalised

DARWIN EU® - Population demographics and disease frequency across the DARWIN EU® network

Belgium

Croatia

Estonia

France

Germany

Greece

Hungary

Netherlands

Norway

Portugal

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000000962

First published:

24/03/2026

Last updated 08/04/2026

Study Ongoing

DARWIN EU® - Azathioprine - user characteristics

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000322

First published:

26/09/2024

Last updated 29/01/2025

Study Ongoing

DARWIN EU® – Prevalence of selected cancers

Croatia

Denmark

Germany

Netherlands

Norway

EU PAS number:

EUPAS1000000715

First published:

19/08/2025

Last updated 12/03/2026

Study Finalised

DARWIN EU® - Characterisation of aliskiren users

Denmark

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000768

First published:

06/10/2025

Last updated 27/01/2026

Study Finalised

DARWIN EU® - Prescription trends of ketamine and esketamine

Denmark

Finland

France

Germany

Spain

United Kingdom

EU PAS number:

EUPAS1000000436

First published:

13/01/2025

Last updated 10/03/2026

Study Finalised

DARWIN EU® – Drug Utilisation Study of terbinafine-containing products

Croatia

Denmark

Finland

Germany

Spain

United Kingdom

EU PAS number:

EUPAS1000000790

First published:

23/10/2025

Last updated 30/01/2026

Study Finalised

DARWIN EU® - Characterising interstitial lung disease in Europe

France

Germany

Spain

United Kingdom

EU PAS number:

EUPAS1000000172

First published:

24/05/2024

Last updated 05/02/2025

Study Ongoing

DARWIN EU® - Drug utilisation study of intramuscular depot olanzapine

Croatia

Denmark

Germany

Hungary

Sweden

EU PAS number:

EUPAS1000000980

First published:

14/04/2026

Last updated 14/04/2026

Study Ongoing

DARWIN EU® - Use of antiretroviral therapies in paediatric patients

Germany

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000545

First published:

09/04/2025

Last updated 23/03/2026

Study Ongoing

DARWIN EU® - Alzheimer’s Disease: Incidence, Prevalence, and Individuals' Characteristics

Croatia

Denmark

Germany

Netherlands

United Kingdom

EU PAS number:

EUPAS1000000826

First published:

10/11/2025

Last updated 11/03/2026

Study Finalised

DARWIN EU® - RR2 Drug utilisation study of prescription opioids

Croatia

Finland

Germany

Hungary

Italy

Portugal

Sweden

EU PAS number:

EUPAS1000000615

First published:

11/06/2025

Last updated 23/01/2026

Study Finalised

DARWIN EU® - Assessment of immunoglobulin use in clinical practice

Denmark

France

Germany

United Kingdom

EU PAS number:

EUPAS1000000823

First published:

10/11/2025

Last updated 23/01/2026

Study Planned

DARWIN EU® - Encephalitis risk in pediatric varicella vaccine recipients

Denmark

Finland

Norway

Spain

EU PAS number:

EUPAS1000000813

First published:

06/11/2025

Last updated 05/01/2026

Study Ongoing

DARWIN EU® - RR1 Drug Utilisation Study of prescription opioids

Belgium

Denmark

Estonia

France

Netherlands

Norway

Spain

EU PAS number:

EUPAS1000000479

First published:

11/02/2025

Last updated 07/11/2025

Study Finalised

DARWIN EU® - Drug Utilisation Study on GLP-1 Receptor Agonists

Belgium

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000223

First published:

20/06/2024

Last updated 19/12/2024

Study Finalised

DARWIN EU® - CGRP antagonists - Treatment patterns and users characteristics

Croatia

Finland

Germany

Spain

EU PAS number:

EUPAS1000000240

First published:

05/07/2024

Last updated 11/11/2024

Study Finalised

DARWIN EU® Prevalence of rare blood cancers in Europe

Belgium

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS50800

First published:

31/01/2023

Last updated 25/09/2024

Study Finalised

DARWIN EU® Characterization of patients with chronic hepatitis B and C

Estonia

France

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS107650

First published:

28/11/2023

Last updated 25/09/2024

Study Finalised

DARWIN EU® - Monitoring prescription of essential medicines administered in ICU

Finland

France

Greece

Hungary

Portugal

Spain

EU PAS number:

EUPAS1000000534

First published:

01/04/2025

Last updated 23/03/2026

Study Finalised

DARWIN EU® - Capturing suicidality and depression related variables in databases

Denmark

Estonia

Finland

France

Germany

Greece

Netherlands

Norway

Portugal

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000000825

First published:

10/11/2025

Last updated 23/03/2026

Study Ongoing

DARWIN EU® - RR Childhood hypertension and sartans prescribing in children

Croatia

Denmark

Finland

France

Germany

Hungary

Netherlands

Norway

Spain

EU PAS number:

EUPAS1000000714

First published:

18/08/2025

Last updated 19/03/2026

Study Finalised

DARWIN EU® - Characterisation of individuals with cystic fibrosis in Europe

Croatia

Denmark

France

Germany

United Kingdom

EU PAS number:

EUPAS1000000709

First published:

18/08/2025

Last updated 11/02/2026

Study Finalised

DARWIN EU® - Treatment characterisation and post-diagnosis outcomes in Alzheimer’s disease

Croatia

Denmark

Germany

Netherlands

EU PAS number:

EUPAS1000000827

First published:

10/11/2025

Last updated 17/12/2025

Study Planned

DARWIN EU® - Clozapine and the incidence of agranulocytosis over time

Croatia

Denmark

Finland

Germany

Spain

EU PAS number:

EUPAS1000000549

First published:

11/04/2025

Last updated 11/07/2025

Study Finalised

DARWIN EU® Monitoring prescription of essential medicines administered in ICU

France

Portugal

Spain

EU PAS number:

EUPAS1000000089

First published:

27/03/2024

Last updated 15/01/2025

Study Finalised

DARWIN EU® Use of take-home naloxone for opioid overdose treatment

Belgium

Germany

Spain

United Kingdom

EU PAS number:

EUPAS105644

First published:

11/07/2023

Last updated 11/07/2024

Study Finalised

DARWIN EU® - RR Characterisation of individuals with cystic fibrosis in Europe

France

Hungary

Italy

Norway

Spain

EU PAS number:

EUPAS1000000710

First published:

18/08/2025

Last updated 03/02/2026

Study Finalised

DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications

Denmark

Germany

Spain

Sweden

EU PAS number:

EUPAS1000000678

First published:

21/07/2025

Last updated 21/01/2026

Study Finalised

DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications

Belgium

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000219

First published:

19/06/2024

Last updated 14/03/2025

Study Finalised

DARWIN EU® - Drug utilisation study on medicinal use of cannabis flos

Germany

Netherlands

EU PAS number:

EUPAS1000000228

First published:

25/06/2024

Last updated 19/02/2025

Study Finalised

DARWIN EU® - Drug utilisation study on medicinal use of Pelargonii radix

Belgium

Germany

EU PAS number:

EUPAS1000000150

First published:

13/05/2024

Last updated 27/11/2024

Study Finalised

DARWIN EU® - Suicidality following exposure to doxycycline

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000280

First published:

25/07/2024

Last updated 30/01/2025

Study Finalised

DARWIN EU® - Characterisation of systemic treatments for the management of ovarian cancer

Denmark

France

Netherlands

Norway

EU PAS number:

EUPAS1000000815

First published:

10/11/2025

Last updated 10/03/2026

Study Ongoing

DARWIN EU® - Determinants for use of GLP1 receptor agonists – a drug utilisation study

Belgium

Croatia

Denmark

Finland

Germany

Netherlands

Norway

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000000828

First published:

10/11/2025

Last updated 04/03/2026

Study Ongoing

DARWIN EU® Effectiveness of Human Papillomavirus Vaccines (HPV) to prevent cervical cancer

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000080

First published:

22/03/2024

Last updated 02/03/2026

Study Finalised

DARWIN EU® - Drug utilisation study in individuals with cystic fibrosis in Europe

France

Germany

Italy

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000708

First published:

14/08/2025

Last updated 11/02/2026

Study Finalised

Search all content

Results(96)